| Aug 15 |
CSL Full Year 2024 Earnings: EPS Misses Expectations
|
| Aug 14 |
The CSL Limited (ASX:CSL) Yearly Results Are Out And Analysts Have Published New Forecasts
|
| Aug 13 |
EXEL or CSLLY: Which Is the Better Value Stock Right Now?
|
| Aug 3 |
Is There An Opportunity With CSL Limited's (ASX:CSL) 27% Undervaluation?
|
| Jul 25 |
GMAB vs. CSLLY: Which Stock Is the Better Value Option?
|
| Jul 16 |
CSL Behring Announces Positive Reimbursement Decision in Canada for HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B
|
| Jul 9 |
CSL Seqirus Begins Shipping Its Portfolio of Influenza Vaccines for the 2024/25 Flu Season
|
| Jul 4 |
Those who invested in CSL (ASX:CSL) five years ago are up 42%
|
| Jul 4 |
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
|
| May 30 |
CSL Seqirus, a Proud Champion of Pandemic Preparedness, Announces U.S. Government Award in Response to Avian Influenza
|
